Protara Therapeutics, Inc.
USD3.95
-0.21 (-5.05%)
CEO
Jesse Shefferman
IPO Date
2014-10-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.12
Prev. Close
$4.16
Day Low
$3.83
Day High
$4.12
52W Low
$2.77
52W High
$7.82
Market Cap
$0.15B
Volume
0.26M
| 31,000 |
| $3.94 |
| 16 Jun 2026 | Smith Cynthia | director | A-Award | Acquired | 31,000 | $3.94 |
| 16 Jun 2026 | SARGEN GREGORY | director | A-Award | Acquired | 31,000 | $3.94 |
| 16 Jun 2026 | Huang Jane | director | A-Award | Acquired | 31,000 | $3.94 |
| 16 Jun 2026 | GARCEAU ROGER | director | A-Award | Acquired | 31,000 | $3.94 |
| 16 Jun 2026 | Flannelly Barry P | director | A-Award | Acquired | 31,000 | $3.94 |
| 16 Jun 2026 | BESHAR LUKE M | director | A-Award | Acquired | 31,000 | $3.94 |
| 9 Apr 2026 | Zummo Jacqueline | Chief R&D Officer | S-Sale | Disposed | 1,134 | $5.40 |
| 2 Apr 2026 | Zummo Jacqueline | Chief R&D Officer | S-Sale | Disposed | 22,598 | $5.26 |